![]() We thank our supporters, especially Yorkshire Cancer Research and the Liz Dawn Breast Cancer Appeal for investing in our laboratories and for their ongoing support. Pathology in Leeds has the largest academic pathology training programme in the United Kingdom with an Industrial Clinician scientist, three NIHR Clinical Lecturers, five out-of-programme medical PhD Research Fellows, and five NIHR Academic Clinical Fellows. We publish over 50 papers a year, many in high impact factor journals. We are undertaking translational research in over 34 UK clinical trials in bowel, stomach and oesophageal cancers and run a Yorkshire Bowel Cancer Improvement Programme driven by our data scientists allied with our multidisciplinary teams. Our digital pathology science can be seen at Virtual Pathology at the University of Leeds. We have a major interest in the causation and treatment of gastrointestinal cancer and improving outcomes for individuals affected by this common condition. Our focus is on translational research moving basic scientific advances into patient care, screening, precision medicine and improving patient outcomes. As well as specialised pathology research, our data analytics work in cancer (Downing, Iles, Birch, E Morris (hon)), nutrition (Morris), autoimmune disease (Iles) and Cystic Fibrosis (Birch). ![]() We also investigate new cutting-edge Artificial Intelligence (Kather (hon), Grabsch, Orsi, Quirke, Magee, Treanor) and novel imaging technologies (Brockmoeller) that add insight into pathology research and education. ![]() In pathology we undertake translational research in cancer - gastrointestinal cancer (Lower GI: Quirke, West, Richman, Young, Brockmoeller, Marks, Wood, E Morris (hon) and Gastric and oesophageal cancer: Grabsch, West, Irvine, Hutchins), breast cancer (Hanby), head and neck (Wood, Hutchins) and gynaecological cancer (Orsi) as well as digital pathology (Treanor), molecular pathology (all groups), microbiome (Young, Wood), embryology (Orsi) and cardiovascular disease (Griffin). ![]() We are an academic pathology laboratory that has fused with data science/bioinformatics groups to understand the key drivers in disease and its management. We aim to generate and use data, all the way from disease prevention, screening, molecular/pathological processes to patient and population levels to generate knowledge to enhance patient outcomes. We undertake pathology undergraduate and post graduate education and conduct translational research and support disease prevention, screening and treatment through clinical trials/studies to improve patient outcomes, including the application of new cutting edge technologies. Data scientists are critical to the future of the Division. Data is fundamental to understanding human behaviours in populations and medicine and driving translational science with data science expertise in bowel cancer, nutrition, molecular epidemiology and liver disease. bowel, oesophageal, gastric, gynaecological and head and neck as well as in digital pathology/artificial intelligence, molecular pathology, embryology, cardiovascular disease and the microbiome in health and disease. ![]() We undertake translational research across a number of different types of cancer e.g. Group summary: The Division of Pathology and Data Analytics is a fusion of academic pathology with data analytics teams to allow us to fully understand the importance of pathology/data advances to patient outcomes. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |